Therapeutic Touch in Cancer Patients Receiving Palliative Care
The Effect of Therapeutic Touch on Sleep Quality and Fatigue Severity in Advanced Cancer Patients in the Palliative Care Setting: A Randomized Controlled Trial
1 other identifier
interventional
61
1 country
1
Brief Summary
This study aims to examine the effect of therapeutic touch applied to advanced cancer patients receiving palliative care on sleep quality and fatigue severity. This is a randomized controlled experimental study using a pretest-posttest design. The study includes advanced-stage cancer patients receiving support in a palliative care unit. Research data will be collected from patients between March and August 2024 using face-to-face interviews. The intervention group will receive therapeutic touch for 20 minutes per day for 5 consecutive days, while the control group will continue to receive routine palliative care. Data will be collected using a Personal Information Form, the Richards-Campbell Sleep Questionnaire (RCSQ), and the Fatigue Severity Scale (FSS).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Mar 2024
Shorter than P25 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedFirst Submitted
Initial submission to the registry
March 31, 2026
CompletedFirst Posted
Study publicly available on registry
April 13, 2026
CompletedApril 13, 2026
April 1, 2026
5 months
March 31, 2026
April 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sleep Quality
Sleep quality measured by the Richards-Campbell Sleep Questionnaire (RCSQ). The scale consists of 5 items scored from 0 to 100. Higher scores indicate better sleep quality.
Baseline and immediately after 5-day intervention
Secondary Outcomes (1)
Fatigue Severity
Baseline and immediately after 5-day intervention
Study Arms (2)
therapeutic touch intervention group
EXPERIMENTALScales were applied to the intervention group in the first interview and pre-test data were obtained. In the next process, therapeutic touch was performed to the intervention group for approximately 10-15 minutes on the head, shoulders, hands and feet starting at 22:00 at night for 5 days on weekdays within the scope of the research.
Control: Routine Palliative Care Group
ACTIVE COMPARATORControl group continued with routine palliative care protocols. No therapeutic touch or other specific touch-based intervention was applied. Scales were applied at the same time points as the intervention group.
Interventions
Participants continued with routine palliative care protocols. No therapeutic touch or other specific touch-based intervention was applied.
Therapeutic touch was applied to the head, shoulders, hands and feet for approximately 10-15 minutes per day for 5 consecutive days. The application was performed between 18:00-22:00 in the patient's room with privacy ensured. The protocol consisted of light, rhythmic touches based on the effleurage (stroking) technique.
Eligibility Criteria
You may qualify if:
- years of age or older
- Pathologically confirmed advanced-stage cancer (stage 3-4)
- Receiving palliative care treatment
- Richards-Campbell Sleep Questionnaire (RCSQ) score ≤50
- Fatigue Severity Scale (FSS) score ≥4
- Mini-Mental Test score ≥24
You may not qualify if:
- Known diagnosis of a major sleep disorder
- Presence of acute infection
- Widespread dermatological lesions compromising skin integrity (e.g., ulcer, eczema)
- Dementia, delirium, or severe cognitive impairment
- Hearing or vision loss that would hinder therapeutic communication
- Medical condition that would contraindicate the application as determined by the palliative care team
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erzurum City Hospital Palliative Care Service
Erzurum, Merkez, 02040, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 31, 2026
First Posted
April 13, 2026
Study Start
March 1, 2024
Primary Completion
August 1, 2024
Study Completion
August 1, 2024
Last Updated
April 13, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to confidentiality and privacy concerns. The data contain sensitive patient information and institutional review board approval does not include data sharing.